5 studies found for:    21696307 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Conditions: Hepatitis C, Chronic;   Human Immunodeficiency Virus
Intervention: Drug: DAA against HCV
2 Recruiting Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Conditions: Hepatitis C,;   Cirrhosis
Interventions: Drug: Telaprevir;   Drug: Boceprevir;   Drug: Peg-IFN;   Drug: Ribavirin
3 Active, not recruiting Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
Condition: Hepatitis C Infection
Intervention:
4 Terminated Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism
Condition: Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: telaprevir
5 Completed
Has Results
A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)
Condition: Hepatitis C
Interventions: Biological: Pegylated Interferon Alfa 2a;   Drug: Telaprevir;   Drug: Ribavirin;   Other: Placebo

Indicates status has not been verified in more than two years